Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Nogo and axon regeneration.

Martin E Schwab1

  • 1Brain Research Institute University of Zurich, and Department of Biology, Swiss Federal Institute of Technology, Winterthurerstrasse 190, 8057 Zurich, Switzerland. schwab@hifo.unizh.ch

Current Opinion in Neurobiology
|March 17, 2004
PubMed
Summary

Blocking Nogo-A, a neurite growth inhibitor in the central nervous system (CNS), promotes axonal regeneration and functional recovery after spinal cord injury. Therapies targeting Nogo-A pathways enhance nerve repair in mammals.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

The Integrated Neurological Change Score Is a Sensitive Neurological Composite Measure to Evaluate Cervical Spinal Cord Injury Trials.

Journal of neurotrauma·2026
Same author

Anti-Nogo-A NG101 treatment induces changes in spinal cord micro- and macrostructure following spinal cord injury.

Nature communications·2026
Same author

Enhanced clinical trial stratification in spinal cord injury: the value of electrophysiology.

Brain : a journal of neurology·2025
Same author

Cuneiform Nucleus Stimulation Can Assist Gait Training to Promote Locomotor Recovery in Individuals With Incomplete Tetraplegia.

Annals of neurology·2025
Same author

Preclinical Evidence of Nogo-A Inhibition in Stroke Recovery: A Scoping Review.

Stroke·2025
Same author

Crossing the Valley of Death in Spinal Cord Injury: Learning from Successful Translators.

Neurotrauma reports·2025

Area of Science:

  • Neuroscience
  • Regenerative Medicine
  • Neurobiology

Background:

  • Nogo-A is a key inhibitor of axonal regeneration in the adult mammalian central nervous system (CNS).
  • It is found in oligodendrocytes and CNS myelin, hindering nerve repair after injury.
  • Understanding Nogo-A's role is critical for developing therapies for CNS damage.

Purpose of the Study:

  • To investigate the efficacy of blocking Nogo-A signaling pathways in promoting axonal regeneration.
  • To assess the impact of these interventions on functional recovery following spinal cord injury.

Main Methods:

  • In vivo application of Nogo-A neutralizing antibodies.
  • Administration of peptides blocking the Nogo receptor (NgR).
  • Use of Rho-A and ROCK pathway inhibitors.

Main Results:

  • Long-distance axonal regeneration was observed in treated rats and mice.
  • Significant compensatory sprouting of nerve fibers occurred.
  • Marked enhancement in functional recovery was documented post-treatment.

Conclusions:

  • Targeting Nogo-A and its downstream signaling pathways effectively promotes axonal regeneration and functional recovery in the injured CNS.
  • These findings highlight the therapeutic potential of Nogo-A blockade for spinal cord injury and other CNS disorders.
  • Further research into Nogo-A pathway modulation could lead to novel treatments for neurological damage.

Related Experiment Videos